Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

Bengt I. Eriksson; Giancarlo Agnelli; Alexander S. Gallus; Michael R. Lassen; Martin H. Prins; Ronny W. Renfurm; Makoto Kashiwa; Alexander G. G. Turpie

doi:10.1160/TH13-04-0296

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

Bengt I. Eriksson^*, Giancarlo Agnelli, Alexander S. Gallus, Michael R. Lassen, Martin H. Prins, Ronny W. Renfurm, Makoto Kashiwa, Alexander G. G. Turpie

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	213-225
Journal	Thrombosis and Haemostasis
Volume	111
Issue number	2
DOIs	https://doi.org/10.1160/TH13-04-0296
Publication status	Published - Feb 2014

Keywords

Darexaban
enoxaparin
orthopaedic surgery
venous thromboembolism
bleeding

Access to Document

10.1160/TH13-04-0296

Cite this

Eriksson, B. I., Agnelli, G., Gallus, A. S., Lassen, M. R., Prins, M. H., Renfurm, R. W., Kashiwa, M., & Turpie, A. G. G. (2014). Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3). Thrombosis and Haemostasis, 111(2), 213-225. https://doi.org/10.1160/TH13-04-0296

Eriksson, Bengt I. ; Agnelli, Giancarlo ; Gallus, Alexander S. ; Lassen, Michael R. ; Prins, Martin H. ; Renfurm, Ronny W. ; Kashiwa, Makoto ; Turpie, Alexander G. G. / Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3). In: Thrombosis and Haemostasis. 2014 ; Vol. 111, No. 2. pp. 213-225.

@article{24aec6c52d6b4e798711c91d757f68fa,

title = "Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)",

keywords = "Darexaban, enoxaparin, orthopaedic surgery, venous thromboembolism, bleeding",

author = "Eriksson, {Bengt I.} and Giancarlo Agnelli and Gallus, {Alexander S.} and Lassen, {Michael R.} and Prins, {Martin H.} and Renfurm, {Ronny W.} and Makoto Kashiwa and Turpie, {Alexander G. G.}",

year = "2014",

month = feb,

doi = "10.1160/TH13-04-0296",

language = "English",

volume = "111",

pages = "213--225",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Georg Thieme Verlag",

number = "2",

}

Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3). / Eriksson, Bengt I.; Agnelli, Giancarlo; Gallus, Alexander S.; Lassen, Michael R.; Prins, Martin H.; Renfurm, Ronny W.; Kashiwa, Makoto; Turpie, Alexander G. G.

In: Thrombosis and Haemostasis, Vol. 111, No. 2, 02.2014, p. 213-225.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)

AU - Eriksson, Bengt I.

AU - Agnelli, Giancarlo

AU - Gallus, Alexander S.

AU - Lassen, Michael R.

AU - Prins, Martin H.

AU - Renfurm, Ronny W.

AU - Kashiwa, Makoto

AU - Turpie, Alexander G. G.

PY - 2014/2

Y1 - 2014/2

KW - Darexaban

KW - enoxaparin

KW - orthopaedic surgery

KW - venous thromboembolism

KW - bleeding

U2 - 10.1160/TH13-04-0296

DO - 10.1160/TH13-04-0296

M3 - Article

C2 - 24136153

VL - 111

SP - 213

EP - 225

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 2

ER -